Rocket Lab Just Won $663 Million in Space Force Contracts. Only the Bigger One Waits for a Rocket That Has Never Flown.

Rocket Lab won two Space Force contracts totaling $663 million: a $397 million SB-AMTI award to build, launch, and operate Flatellite satellites, and a $266 million deal for 12 guaranteed suborbital missile-defense launches from Alaska starting as soon as late 2026. The awards come alongside strong recent momentum—Q1 revenue of $200.3 million (+63.5% YoY) and a record $2.2 billion backlog (+20.2%)—but the bigger $397 million portion is gated behind Neutron’s debut launch, which the company still targets for late 2026 (previously expected 2025). Shares rose ~6% on the news, while valuation remains stretched at ~65x trailing revenue and the company is still loss-making (about -$183 million over the trailing-12 months).

Analysis

The near-term market mistake is likely to treat backlog growth as if it were near-term revenue. The smaller contract is real, but it mostly validates an existing launch cadence; the larger award is economically valuable only if Neutron becomes an operational asset, so the stock is still being priced on an execution milestone rather than a durable earnings step-up. That gap matters because RKLB’s current valuation already discounts several quarters of flawless schedule performance, leaving limited room for another delay without multiple compression.

The second-order winner is the company’s strategic relevance to defense customers, but the first-order loser is margin flexibility: vertical integration usually improves lifetime economics only after the launch vehicle is proven, while upfront capex, inventory, and operating complexity hit cash flow first. In the next 1-3 months, the key catalyst is not the order book but management’s language on Neutron timing, test cadence, and any change to the late-year debut window. A successful first flight would likely re-rate the name; another slip would likely push the program’s revenue and investor confidence right by 2-4 quarters.

Contrarian view: the consensus may be underestimating how slow government awards can convert into realized P&L, especially when the same announcement increases the burden of proof on an unflown platform. The stock can keep levitating on headline momentum, but the risk/reward still looks better as an event-driven trade than as a fresh core long. If Neutron is late, the headline backlog becomes a financing-and-execution story, not an earnings story.

Key Decisions for Investors

• Avoid initiating new RKLB longs into the post-news pop; use strength to trim or hold cash until management reaffirms Neutron timing on the next earnings call (days to 1 month).
• For event exposure only, consider a small RKLB call spread expiring after the next launch-readout, but only if the company gives a firm first-flight window; otherwise the optionality is too expensive relative to execution risk (1-3 months).
• Pair trade: long XAR / short RKLB to express broad aerospace-defense demand while isolating single-name launch execution risk; cover the short on a confirmed successful Neutron debut (1-6 months).
• Set a hard thesis break if Neutron slips again or if management lowers launch cadence/backlog conversion guidance; that would argue for a lower multiple and a faster de-risking of the position.